Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI
暂无分享,去创建一个
Marco Rovaris | Domenico Caputo | Massimo Filippi | Paola Valsasina | Maria Pia Sormani | Giancarlo Comi | Antonio Bertolotto | Gian Luigi Mancardi | Antonio Gallo | Beatrice Benedetti | Angelo Ghezzi | Enrico Montanari | Roberto Bergamaschi | Vittorio Martinelli | M. Rovaris | M. Filippi | P. Valsasina | M. Sormani | V. Martinelli | G. Comi | A. Ghezzi | R. Bergamaschi | A. Gallo | B. Benedetti | G. Mancardi | D. Caputo | E. Montanari | A. Bertolotto
[1] J V Hajnal,et al. MR imaging of anisotropically restricted diffusion of water in the nervous system: technical, anatomic, and pathologic considerations. , 1991, Journal of computer assisted tomography.
[2] G. Comi,et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.
[3] M. Rovaris,et al. Cognitive dysfunction in patients with mildly disabling relapsing–remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging , 2002, Journal of the Neurological Sciences.
[4] M Cercignani,et al. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. , 2000, Archives of neurology.
[5] M. Cercignani,et al. A QUANTITATIVE STUDY OF WATER DIFFUSION IN MS LESIONS AND NAWM USING ECHO-PLANAR IMAGING , 2000 .
[6] M Filippi,et al. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. , 1999, AJNR. American journal of neuroradiology.
[7] David H. Miller,et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. , 2002, The New England journal of medicine.
[8] J. Ashburner,et al. Multimodal Image Coregistration and Partitioning—A Unified Framework , 1997, NeuroImage.
[9] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[10] M Rovaris,et al. Two-year follow-up study of primary and transitional progressive multiple sclerosis , 2002, Multiple sclerosis.
[11] G. Comi,et al. Magnetization transfer imaging to monitor the evolution of MS , 2000, Neurology.
[12] Marco Rovaris,et al. Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis. , 2003, AJNR. American journal of neuroradiology.
[13] D L Hill,et al. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. , 1997, Medical physics.
[14] Marco Rovaris,et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. , 2003, Brain : a journal of neurology.
[15] L. Kappos,et al. Clinical–MRI correlations in a European trial of interferon beta-1b in secondary progressive MS , 2001, Neurology.
[16] S. Reingold,et al. Defining the clinical course of multiple sclerosis , 1996, Neurology.
[17] A. Thompson,et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[18] P. Matthews,et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.
[19] M Cercignani,et al. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[20] A J Thompson,et al. Diagnostic criteria for primary progressive multiple sclerosis: A position paper , 2000, Annals of neurology.
[21] Ludwig Kappos,et al. Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis , 1998, The Lancet.
[22] Marco Rovaris,et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. , 2002, Archives of neurology.
[23] A J Thompson,et al. PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS , 1997 .
[24] P. Grenier,et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.
[25] P Kapeller,et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[26] D. Miller,et al. Interferon β-1a in primary progressive MS , 2003, Neurology.
[27] J. Dehmeshki,et al. The normal appearing grey matter in primary progressive multiple sclerosis , 2003, Journal of Neurology.
[28] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[29] F. Barkhof,et al. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. , 1993, Brain : a journal of neurology.
[30] Massimo Filippi,et al. MRI techniques to monitor MS evolution: The present and the future , 2002, Neurology.
[31] M. Blinkenberg,et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS , 2000, Neurology.
[32] A J Thompson,et al. Clinical and Magnetic Resonance Imaging Predictors of Disability in Primary and Secondary Progressive Multiple Sclerosis , 1996, Multiple sclerosis.
[33] R. Ordidge,et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis , 2003, Journal of Neurology.
[34] P. Matthews,et al. Normalized Accurate Measurement of Longitudinal Brain Change , 2001, Journal of computer assisted tomography.
[35] C Caltagirone,et al. Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. , 2000, AJNR. American journal of neuroradiology.
[36] J. Pekar,et al. Imaging of diffusion and microcirculation with gradient sensitization: Design, strategy, and significance , 1991, Journal of magnetic resonance imaging : JMRI.
[37] M Cercignani,et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis , 2001, Neurology.
[38] Carlo Pozzilli,et al. A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. , 2002, Magnetic resonance imaging.
[39] I. Allen,et al. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.
[40] A. Thompson,et al. Primary progressive multiple sclerosis: a 5-year clinical and MR study. , 2003, Brain : a journal of neurology.
[41] M Cercignani,et al. Weekly diffusion-weighted imaging of normal-appearing white matter in MS , 2000, Neurology.
[42] G J Barker,et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. , 2000, Brain : a journal of neurology.
[43] Adolf Pfefferbaum,et al. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. , 2003, AJNR. American journal of neuroradiology.
[44] G. Comi,et al. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI , 2000, Neurology.
[45] P. Basser,et al. MR diffusion tensor spectroscopy and imaging. , 1994, Biophysical journal.
[46] M. Horsfield,et al. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging , 1999, Magnetic resonance in medicine.
[47] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[48] A J Thompson,et al. A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.
[49] A. J. Thompson,et al. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis , 2003, Journal of Neurology.
[50] Massimo Filippi,et al. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. , 2002, AJNR. American journal of neuroradiology.
[51] A. Thompson,et al. One year follow up study of primary and transitional progressive multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.